Literature DB >> 15309386

Cancer risk estimates for gamma-rays with regard to organ-specific doses. Part I: All solid cancers combined.

Linda Walsh1, Werner Rühm, Albrecht M Kellerer.   

Abstract

A previous analysis of the solid cancer mortality data for 1950-1990 from the Japanese life-span study of the A-bomb survivors has assessed the solid cancer risk coefficients for gamma-rays in terms of the low dose risk coefficient ERR/Gy, i.e. the initial slope of the ERR vs. dose relation, and also in terms of the more precisely estimated intermediate dose risk coefficient, ERR(D1)/D1, for a reference dose, D1, which was chosen to be 1 Gy. The computations were performed for tentatively assumed values 20-50 of the neutron RBE against the reference dose and in terms of organ-averaged doses, rather than the traditionally applied colon doses. The resulting risk estimate for a dose of 1 Gy was about half as large as the most recent UNSCEAR estimate. The present assessment repeats the earlier analysis with two major extensions. It parallels computations based on organ-average doses with computations based on organ-specific doses and it updates the previous results by using the cancer mortality data for 1950-1997 which have recently been made available. With an assumed neutron RBE of 35, the resulting intermediate dose estimate of the lifetime attributable risk (LAR) for solid cancer mortality for a working population (ages 25-65 years) is 0.059/Gy with the attained-age model, and 0.044/Gy with the age-at-exposure model. For a population of all ages, 0.055/Gy is obtained with the attained-age model and 0.073/Gy with the age-at-exposure model. These values are up to about 20% higher than those obtained in the previous analysis with the 1950-1990 data. However, considerably more curvature in the dose-effect relation is now supported by the computations. A dose and dose-rate reduction factor DDREF=2 is now much more in line with the data than before. With this factor the LAR for a working population is--averaged over the age-at-exposure and the age-attained model--equal to 0.026/Gy. This is only half as large as the current ICRP estimate which is also based on the assumption DDREF=2.

Entities:  

Mesh:

Year:  2004        PMID: 15309386     DOI: 10.1007/s00411-004-0248-5

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  11 in total

1.  Radiation-related cancer risks at low doses among atomic bomb survivors.

Authors:  D A Pierce; D L Preston
Journal:  Radiat Res       Date:  2000-08       Impact factor: 2.841

2.  Risk estimation for fast neutrons with regard to solid cancer.

Authors:  A M Kellerer; L Walsh
Journal:  Radiat Res       Date:  2001-12       Impact factor: 2.841

3.  On the conversion of solid cancer excess relative risk into lifetime attributable risk.

Authors:  A M Kellerer; E A Nekolla; L Walsh
Journal:  Radiat Environ Biophys       Date:  2001-12       Impact factor: 1.925

4.  Error bands for the linear-quadratic dose-effect relation.

Authors:  A M Kellerer
Journal:  Radiat Environ Biophys       Date:  2003-07-08       Impact factor: 1.925

5.  Allowing for random errors in radiation dose estimates for the atomic bomb survivor data.

Authors:  D A Pierce; D O Stram; M Vaeth
Journal:  Radiat Res       Date:  1990-09       Impact factor: 2.841

6.  Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk.

Authors:  James Bennett; Mark P Little; Sylvia Richardson
Journal:  Radiat Environ Biophys       Date:  2004-11-25       Impact factor: 1.925

7.  Radiation dose dependences in the atomic bomb survivor cancer mortality data: a model-free visualization.

Authors:  M Chomentowski; A M Kellerer; D A Pierce
Journal:  Radiat Res       Date:  2000-03       Impact factor: 2.841

8.  Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.

Authors:  D A Pierce; Y Shimizu; D L Preston; M Vaeth; K Mabuchi
Journal:  Radiat Res       Date:  1996-07       Impact factor: 2.841

9.  Cancer risk estimates for gamma-rays with regard to organ-specific doses Part II: site-specific solid cancers.

Authors:  Linda Walsh; Werner Rühm; Albrecht M Kellerer
Journal:  Radiat Environ Biophys       Date:  2004-11-13       Impact factor: 1.925

10.  Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.

Authors:  Dale L Preston; Yukiko Shimizu; Donald A Pierce; Akihiko Suyama; Kiyohiko Mabuchi
Journal:  Radiat Res       Date:  2003-10       Impact factor: 2.841

View more
  13 in total

Review 1.  A short review of model selection techniques for radiation epidemiology.

Authors:  Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2007-04-28       Impact factor: 1.925

2.  The linear no-threshold relationship is inconsistent with radiation biologic and experimental data.

Authors:  Maurice Tubiana; Ludwig E Feinendegen; Chichuan Yang; Joseph M Kaminski
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

3.  Modeling of cell inactivation and carcinogenesis in the atomic bomb survivors with applications to the mortality from all solid, stomach and liver cancer.

Authors:  Peter Jacob; Linda Walsh; Markus Eidemüller
Journal:  Radiat Environ Biophys       Date:  2008-05-15       Impact factor: 1.925

4.  Neutron relative biological effectiveness for solid cancer incidence in the Japanese A-bomb survivors: an analysis considering the degree of independent effects from γ-ray and neutron absorbed doses with hierarchical partitioning.

Authors:  Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2012-11-17       Impact factor: 1.925

5.  Measurements of fast neutrons in Hiroshima by use of (39)Ar.

Authors:  Eckehart Nolte; Werner Rühm; H Hugo Loosli; Igor Tolstikhin; Kazuo Kato; Thomas C Huber; Stephen D Egbert
Journal:  Radiat Environ Biophys       Date:  2006-01-21       Impact factor: 1.925

6.  Cancer risk estimates for gamma-rays with regard to organ-specific doses Part II: site-specific solid cancers.

Authors:  Linda Walsh; Werner Rühm; Albrecht M Kellerer
Journal:  Radiat Environ Biophys       Date:  2004-11-13       Impact factor: 1.925

Review 7.  Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy.

Authors:  Harald Paganetti
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

8.  Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.

Authors:  Uwe Schneider; Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2007-12-21       Impact factor: 1.925

9.  Hypofractionated radiotherapy has the potential for second cancer reduction.

Authors:  Uwe Schneider; Jürgen Besserer; Andreas Mack
Journal:  Theor Biol Med Model       Date:  2010-02-11       Impact factor: 2.432

10.  Second cancers after fractionated radiotherapy: stochastic population dynamics effects.

Authors:  Rainer K Sachs; Igor Shuryak; David Brenner; Hatim Fakir; Lynn Hlatky; Philip Hahnfeldt
Journal:  J Theor Biol       Date:  2007-08-12       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.